Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of P1101 in Early Myelofibrosis

NCT02370329 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02370329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of P1101 in Early Myelofibrosis
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
August 12, 2015
Completion date
November 30, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary myelofibrosis, secondary myelofibrosis